TOXINS2026:ClinicalUpdatesonGalderma’sLeadingNeuromodulatorPortfolioFurtherReinforceItsLeadershipinInjectableAesthetics
===2026/1/14 14:24:31===
Jessica Cohen
Investor Relations and Strategy Director
jessica.cohen@galderma.com
+41 21 642 76 43
=*=*=*=*=*=
当前为第10/10页
上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页
